Botulinum Toxin for Trigeminal Neuralgia

NCT03331913 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Trigeminal Neuralgia

Interventions

DRUG: Botulinum Toxin type A (intradermal / submucosal injection at pain area)
DRUG: Botulinum Toxin type A (intra-masseter injection on the ipsilateral of pain involved)

Sponsor

The First Affiliated Hospital of Zhengzhou University